FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313304013> ?p ?o ?g. }

• W4313304013 abstract "Attenuated Oxaliplatin efficacy is a challenge in treating colorectal cancer (CRC) patients, contributory to the failure in chemotherapy and the risks in relapse and metastasis. However, the mechanism of Oxaliplatin de-efficacy during CRC treatment has not been completely elucidated.Microarray screening, western blot and qPCR on clinic CRC samples were conducted to select the target gene ABCC10 transporter. The Cancer Genome Atlas data was analyzed to figure out the correlation between the clinical manifestation and ABCC10 expression. ABCC10 knock-down in CRC cells was conducted to identify its role in the Oxaliplatin resistance. Cell counting kit-8 assay was conducted to identify the CRC cell viability and Oxaliplatin IC50. Flow cytometry was conducted to detect the cell apoptosis exposed to Oxaliplatin. The intracellular Oxaliplatin accumulation was measured by ultra-high performance liquid chromatography coupled to tandem mass spectrometry.CRC patients with higher ABCC10 were prone to relapse and metastasis. Differential ABCC10 expression in multiple CRC cell lines revealed a strong positive correlation between ABCC10 expression level and decreased Oxaliplatin response. In ABCC10 knock-down CRC cells the Oxaliplatin sensitivity was evidently elevated due to an increase of intracellular Oxaliplatin accumulation resulted from the diminished drug efflux. To explore a strategy to block ABCC10 in CRC cells, we paid a special interest in the endoplasmic reticulum stress (ERS) / unfolded protein response (UPR) that plays a dual role in tumor development. We found that neither the inhibition of ERS nor the induction of mild ERS had anti-CRC effect. However, the CRC cell viability was profoundly decreased and the pro-apoptotic factor CHOP and apoptosis were increased by the induction of intense ERS. Significantly, the Oxaliplatin sensitivity of CRC cells was enhanced in response to the intense ERS, which was blocked by inhibiting IRE1α branch of UPR. Finally, we figured out that the intense ERS down-regulated ABCC10 expression via regulated IRE1-dependent decay activity.Oxaliplatin was a substrate of ABCC10 efflux transporter. The intense ERS/IRE1α enhanced Oxaliplatin efficacy through down-regulating ABCC10 in addition to inducing CHOP. We suggested that introduction of intense ERS/UPR could be a promising strategy to restore chemo-sensitivity when used in combination with Oxaliplatin or other chemotherapeutic drugs pumped out by ABCC10." @default.
• W4313304013 created "2023-01-06" @default.
• W4313304013 creator A5029936869 @default.
• W4313304013 creator A5035358476 @default.
• W4313304013 creator A5044712358 @default.
• W4313304013 creator A5054957068 @default.
• W4313304013 creator A5064530138 @default.
• W4313304013 creator A5066345375 @default.
• W4313304013 creator A5074343752 @default.
• W4313304013 creator A5078955972 @default.
• W4313304013 date "2022-12-30" @default.
• W4313304013 modified "2023-09-25" @default.
• W4313304013 title "Intense endoplasmic reticulum stress (ERS) / IRE1α enhanced Oxaliplatin efficacy by decreased ABCC10 in colorectal cancer cells" @default.
• W4313304013 cites W1981140460 @default.
• W4313304013 cites W1988867169 @default.
• W4313304013 cites W2006583554 @default.
• W4313304013 cites W2012184780 @default.
• W4313304013 cites W2012431429 @default.
• W4313304013 cites W2028397177 @default.
• W4313304013 cites W2051776823 @default.
• W4313304013 cites W2052645281 @default.
• W4313304013 cites W2055904567 @default.
• W4313304013 cites W2067815150 @default.
• W4313304013 cites W2079197876 @default.
• W4313304013 cites W2110214407 @default.
• W4313304013 cites W2110789354 @default.
• W4313304013 cites W2117640334 @default.
• W4313304013 cites W2126371858 @default.
• W4313304013 cites W2149157363 @default.
• W4313304013 cites W2177500163 @default.
• W4313304013 cites W2253669619 @default.
• W4313304013 cites W2496828587 @default.
• W4313304013 cites W2568567825 @default.
• W4313304013 cites W2571903415 @default.
• W4313304013 cites W2744882241 @default.
• W4313304013 cites W2768087678 @default.
• W4313304013 cites W2789694723 @default.
• W4313304013 cites W2792306782 @default.
• W4313304013 cites W2893484599 @default.
• W4313304013 cites W2897704361 @default.
• W4313304013 cites W2901075415 @default.
• W4313304013 cites W2916618634 @default.
• W4313304013 cites W2955522501 @default.
• W4313304013 cites W2971669297 @default.
• W4313304013 cites W2971914964 @default.
• W4313304013 cites W2991274658 @default.
• W4313304013 cites W3007149203 @default.
• W4313304013 cites W3021909056 @default.
• W4313304013 cites W3062435645 @default.
• W4313304013 cites W3092285225 @default.
• W4313304013 cites W3120027938 @default.
• W4313304013 cites W3120588454 @default.
• W4313304013 cites W3153544217 @default.
• W4313304013 cites W3157566098 @default.
• W4313304013 cites W3194874515 @default.
• W4313304013 cites W4200600959 @default.
• W4313304013 cites W4211168195 @default.
• W4313304013 cites W4213255456 @default.
• W4313304013 doi "https://doi.org/10.1186/s12885-022-10415-8" @default.
• W4313304013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36585626" @default.
• W4313304013 hasPublicationYear "2022" @default.
• W4313304013 type Work @default.
• W4313304013 citedByCount "0" @default.
• W4313304013 crossrefType "journal-article" @default.
• W4313304013 hasAuthorship W4313304013A5029936869 @default.
• W4313304013 hasAuthorship W4313304013A5035358476 @default.
• W4313304013 hasAuthorship W4313304013A5044712358 @default.
• W4313304013 hasAuthorship W4313304013A5054957068 @default.
• W4313304013 hasAuthorship W4313304013A5064530138 @default.
• W4313304013 hasAuthorship W4313304013A5066345375 @default.
• W4313304013 hasAuthorship W4313304013A5074343752 @default.
• W4313304013 hasAuthorship W4313304013A5078955972 @default.
• W4313304013 hasBestOaLocation W43133040131 @default.
• W4313304013 hasConcept C121608353 @default.
• W4313304013 hasConcept C126322002 @default.
• W4313304013 hasConcept C185592680 @default.
• W4313304013 hasConcept C190283241 @default.
• W4313304013 hasConcept C2780962732 @default.
• W4313304013 hasConcept C502942594 @default.
• W4313304013 hasConcept C526805850 @default.
• W4313304013 hasConcept C55493867 @default.
• W4313304013 hasConcept C71924100 @default.
• W4313304013 hasConcept C98274493 @default.
• W4313304013 hasConceptScore W4313304013C121608353 @default.
• W4313304013 hasConceptScore W4313304013C126322002 @default.
• W4313304013 hasConceptScore W4313304013C185592680 @default.
• W4313304013 hasConceptScore W4313304013C190283241 @default.
• W4313304013 hasConceptScore W4313304013C2780962732 @default.
• W4313304013 hasConceptScore W4313304013C502942594 @default.
• W4313304013 hasConceptScore W4313304013C526805850 @default.
• W4313304013 hasConceptScore W4313304013C55493867 @default.
• W4313304013 hasConceptScore W4313304013C71924100 @default.
• W4313304013 hasConceptScore W4313304013C98274493 @default.
• W4313304013 hasFunder F4320321001 @default.
• W4313304013 hasFunder F4320322919 @default.
• W4313304013 hasIssue "1" @default.
• W4313304013 hasLocation W43133040131 @default.
• W4313304013 hasLocation W43133040132 @default.
• W4313304013 hasLocation W43133040133 @default.
• W4313304013 hasOpenAccess W4313304013 @default.

• next